In addition, the current results show that AK2 can specifically bind to rhCDK4 and endogenous CDK4 in tumour cells, which indicates that AK2, as a single-chain antibody, maintains its unique biological structure and biological activity in this soluble expression and purification system. Here, CDK4 is linked to neoplasm.